Holoprosencephaly: genes and variants
Explore variant evidence for Holoprosencephaly across 3 analyzed proteins (FGFR1, NSD1, PTCH1). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 27 variants of uncertain significance and 33 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Holoprosencephaly
FGFR1: Fibroblast growth factor receptor 1
Its fibroblast-growth-factor signaling controls proliferation, differentiation, migration, and developmental patterning in many tissues. Germline pathogenic variants can cause hypogonadotropic hypogonadism or craniosynostosis syndromes, while fusions and other activating alterations drive selected cancers.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FGFR1 have source records linked to Holoprosencephaly. Association strength is not clinical gene validity.
NSD1: Histone-lysine N-methyltransferase, H3 lysine-36 specific
It regulates developmental transcription through chromatin modification, including H3K36 methylation. Haploinsufficiency causes Sotos syndrome with childhood overgrowth, characteristic facial features, and developmental delay, while somatic rearrangements occur in some leukemias.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NSD1 have source records linked to Holoprosencephaly. Association strength is not clinical gene validity.
PTCH1: Protein patched homolog 1
It suppresses Smoothened in the absence of Hedgehog ligands and thereby keeps Hedgehog developmental signaling inactive until an appropriate signal is received. Germline loss-of-function variants cause Gorlin syndrome, while somatic pathway activation drives basal-cell carcinoma and other tumors.
0 ClinVar pathogenic / likely pathogenic and 58 uncertain variants in PTCH1 have source records linked to Holoprosencephaly. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): STAG2.
ClinVar pathogenic and likely pathogenic variants linked to Holoprosencephaly
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FGFR1 E294K | 294 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| NSD1 S2181F | 2181 | Pathogenic / likely pathogenic (★★) | |
| FGFR1 E692K | 692 | Protein kinase | Pathogenic / likely pathogenic |
Same protein, different disease
- Hypogonadotropic hypogonadism 2 with or without anosmia also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Holoprosencephaly variants (55 pathogenic / likely pathogenic).
- Pfeiffer syndrome also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Holoprosencephaly variants (18 pathogenic / likely pathogenic).
- Hartsfield-Bixler-Demyer syndrome also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Holoprosencephaly variants (13 pathogenic / likely pathogenic).
- Jackson-Weiss syndrome also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Holoprosencephaly variants (5 pathogenic / likely pathogenic).
- Osteoglophonic dysplasia also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Holoprosencephaly variants (5 pathogenic / likely pathogenic).
- Sotos syndrome also has ClinVar records linked to NSD1 variants; they fall mostly in different places as the Holoprosencephaly variants (82 pathogenic / likely pathogenic).
- Beckwith-Wiedemann syndrome also has ClinVar records linked to NSD1 variants; they fall mostly in different places as the Holoprosencephaly variants (3 pathogenic / likely pathogenic).
Diseases related to Holoprosencephaly
- Sotos syndrome, also linked to NSD1
- Hypogonadotropic hypogonadism 2 with or without anosmia, also linked to FGFR1
- Ovarian cancer, also linked to PTCH1
- Acute myeloid leukemia, also linked to NSD1
- Pfeiffer syndrome, also linked to FGFR1
- Gorlin syndrome, also linked to PTCH1
- Colorectal cancer, also linked to FGFR1
- Non-small cell lung carcinoma, also linked to FGFR1
- Hartsfield-Bixler-Demyer syndrome, also linked to FGFR1
- Idiopathic pulmonary fibrosis, also linked to FGFR1
- Weaver syndrome, also linked to NSD1
- Jackson-Weiss syndrome, also linked to FGFR1
Frequently asked questions
Which genes have records linked to Holoprosencephaly?
This view contains 3 analyzed proteins: FGFR1, NSD1, PTCH1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 27 variants of uncertain significance and 33 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 70 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center